AI-Designed Radiopharmaceuticals: How Machine Learning Is Redefining Precision Cancer Therapy

1

Radiopharmaceutical therapy targets cancer cells more precisely, potentially reducing damage to healthy tissues compared to traditional radiation therapy.
2

Deep learning and generative AI can accelerate the identification and engineering of novel radiopharmaceuticals, reducing development costs.
3

The lack of standardized, high-quality data limits the clinical adoption of machine learning frameworks in radiopharmaceuticals.
4

AI technologies can enhance the specificity of radiopharmaceutical targeting and improve dose calculations for personalized treatment.
5

Generative adversarial networks and deep learning models show promise in predicting patient responses and optimizing radiation dose delivery.

Journal Of Medical Internet Research (Jmir)

1